These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Romanowski EG, Bartels SP, Gordon YJ. Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596 [Abstract] [Full Text] [Related]
5. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model. Romanowski EG, Gordon YJ, Araullo-Cruz T, Yates KA, Kinchington PR. Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446 [Abstract] [Full Text] [Related]
14. Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. de Oliveira CB, Stevenson D, LaBree L, McDonnell PJ, Trousdale MD. Antiviral Res; 1996 Jul; 31(3):165-72. PubMed ID: 8811201 [Abstract] [Full Text] [Related]
19. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir. Gordon YJ, Araullo-Cruz TP, Johnson YF, Romanowski EG, Kinchington PR. Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495 [Abstract] [Full Text] [Related]